Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Ductal carcinoma in situ: what the pathologist needs to know and why.

Bane A.

Int J Breast Cancer. 2013;2013:914053. doi: 10.1155/2013/914053. Epub 2013 Feb 6.

2.

Optimal management of ductal carcinoma in situ of the breast.

Sakorafas GH, Farley DR.

Surg Oncol. 2003 Dec;12(4):221-40. Review.

PMID:
14998563
3.

Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.

Sakorafas GH, Tsiotou AG.

Cancer Treat Rev. 2000 Apr;26(2):103-25. Review.

PMID:
10772968
5.

Tamoxifen in ductal carcinoma in situ.

Daly MB.

Semin Oncol. 2006 Dec;33(6):647-9. Review.

PMID:
17145343
6.

Ductal carcinoma in situ, complexities and challenges.

Leonard GD, Swain SM.

J Natl Cancer Inst. 2004 Jun 16;96(12):906-20. Review.

PMID:
15199110
7.

Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.

Mokbel K.

Int J Fertil Womens Med. 2003 Sep-Oct;48(5):217-25. Review.

PMID:
14626378
8.
9.

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Virnig BA, Tuttle TM, Shamliyan T, Kane RL.

J Natl Cancer Inst. 2010 Feb 3;102(3):170-8. doi: 10.1093/jnci/djp482. Epub 2010 Jan 13. Review.

PMID:
20071685
10.

[The treatment of ductal carcinoma in situ (DCIS) of the breast].

Westenberg AH, Rutgers EJ, Peterse JL, Hendriks JH, Beex LV, van Tienhoven G.

Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2157-61. Review. Dutch.

PMID:
14626831
11.
12.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
13.

Management of ductal carcinoma in situ.

Vezeridis MP, Bland KI.

Surg Oncol. 1994 Dec;3(6):309-25. Review.

PMID:
7773449
14.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000563. doi: 10.1002/14651858.CD000563.pub5. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000563.

PMID:
19588320
15.

Current perspectives of treatment of ductal carcinoma in situ.

Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I.

Cancer Treat Rev. 2010 Nov;36(7):507-17. doi: 10.1016/j.ctrv.2010.03.007. Epub 2010 May 11. Review.

PMID:
20462701
16.

Ductal carcinoma in situ: biology, diagnosis, and new therapies.

Valenzuela M, Julian TB.

Clin Breast Cancer. 2007 Aug;7(9):676-81. Review.

PMID:
17919347
17.

The diagnosis and management of ductal carcinoma in-situ of the breast.

Winchester DP, Jeske JM, Goldschmidt RA.

CA Cancer J Clin. 2000 May-Jun;50(3):184-200. Review.

18.

Is DCIS breast cancer, and how do I treat it?

Bijker N, Donker M, Wesseling J, den Heeten GJ, Rutgers EJ.

Curr Treat Options Oncol. 2013 Mar;14(1):75-87. doi: 10.1007/s11864-012-0217-1. Review.

PMID:
23239193
19.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000563. doi: 10.1002/14651858.CD000563.pub4. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD000563.

PMID:
19160183
20.

Current treatment and clinical trial developments for ductal carcinoma in situ of the breast.

Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM.

Oncologist. 2007 Nov;12(11):1276-87. Review.

Supplemental Content

Support Center